RegulatoryMay 15, 2026, 08:32 AM
Jyong Biotech Files 2025 Annual Report on Form 20-F
AI Summary
Jyong Biotech Ltd. announced the filing of its annual report on Form 20-F with the U.S. Securities and Exchange Commission (SEC) on May 14, 2026. The report covers the fiscal year ended December 31, 2025. Shareholders can access the report on the company's investor relations website and the SEC's website, and may request a free hard copy.
Key Highlights
- Jyong Biotech filed its annual report on Form 20-F for the fiscal year ended December 31, 2025.
- The report was submitted to the U.S. Securities and Exchange Commission (SEC) on May 14, 2026.
- The annual report is accessible on the Company's investor relations website.
- The report is also available on the SEC's website.
- Shareholders can request a free hard copy of the annual report.
Price Impact
More from MENS